{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:54:37Z","timestamp":1792011277365,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.rgmxen.2026.09.008","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:43:31Z","timestamp":1792010611000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastroenteropancreatic neuroendocrine neoplasms: A 20-year experience at a tertiary care medical center in Mexico City"],"prefix":"10.1016","author":[{"given":"S.","family":"Wuotto-Alvarado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gerson-Cwilich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Noguez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmxen.2026.09.008_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021418","article-title":"The complex histopathological and immunohistochemical spectrum of neuroendocrine tumors-an overview of the latest classifications","volume":"24","author":"Gheorghi\u0219an-G\u0103l\u0103\u021beanu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051119","article-title":"Update on epidemiology, diagnosis, and biomarkers in gastroenteropancreatic neuroendocrine neoplasms","volume":"14","author":"Takayanagi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12155138","article-title":"A comprehensive review on neuroendocrine neoplasms: presentation, pathophysiology and management","volume":"12","author":"Sultana","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beem.2015.10.004","article-title":"A short history of neuroendocrine tumours and their peptide hormones","volume":"30","author":"De Herder","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0030","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1590\/S1807-59322011001000002","article-title":"Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases","volume":"66","author":"Estrozi","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"15_suppl","key":"10.1016\/j.rgmxen.2026.09.008_bib0035","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.e15186","article-title":"Prognostic factors of neuroendocrine tumors (NETs) in a Mexican cohort","volume":"31","author":"Camargo","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2d","key":"10.1016\/j.rgmxen.2026.09.008_bib0040","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2023.7111","article-title":"Revisiting the association of ECOG performance status with clinical outcomes in diverse patients with cancer","volume":"22","author":"Kumar","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0045","author":"Hern\u00e1ndez L\u00f3pez"},{"issue":"4_suppl","key":"10.1016\/j.rgmxen.2026.09.008_bib0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1200\/JCO.2022.40.4_suppl.503","article-title":"Neuroendocrine tumors: ten years of experience in a Mexican oncology reference center","volume":"40","author":"Torres-Cisneros","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0055","first-page":"520","article-title":"Neoplasias neuroendocrinas gastro-entero-pancre\u00e1ticas: an\u00e1lisis cl\u00ednico-patol\u00f3gico de 48 casos atendidos en el Hospital \u00c1ngeles del Pedregal de la Ciudad de M\u00e9xico entre 2018 y 2024","volume":"90","author":"S\u00e1nchez-Arregu\u00edna","year":"2025","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3892\/mco.2014.332","article-title":"Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: results from the large database of a multidisciplinary group clinical multicenter study","volume":"2","author":"O\u2019Connor","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12672-018-0354-5","article-title":"Chilean registry for neuroendocrine tumors: a Latin American perspective","volume":"10","author":"Pinto","year":"2019","journal-title":"Horm Cancer"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0070","article-title":"Neuroendocrine tumors: an analysis of prevalence, incidence, and survival in a hospital-based study in Ecuador","volume":"10","author":"Escobar","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3892\/mco.2021.2319","article-title":"Neuroendocrine tumors in Panama: a nationwide database analysis","volume":"15","author":"Cukier","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0080","doi-asserted-by":"crossref","first-page":"440","DOI":"10.21037\/hbsn.2020.04.02","article-title":"Neuroendocrine liver metastases: a contemporary review of treatment strategies","volume":"9","author":"Cloyd","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0085","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000534035","article-title":"Relation between WHO classification and location- and functionality-based classifications of neuroendocrine neoplasms of the digestive tract","volume":"114","author":"Helderman","year":"2024","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0095","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.endonu.2012.10.003","article-title":"Chromogranin A and neuroendocrine tumors","volume":"60","author":"D\u00edaz P\u00e9rez","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000162876","article-title":"Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine tumors","volume":"89","author":"Korse","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0105","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1007\/s12094-018-1881-9","article-title":"Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors","volume":"20","author":"Merino-Casabiel","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000247","article-title":"Chromogranin A as a marker for diagnosis, treatment, and survival in patients with gastroenteropancreatic neuroendocrine neoplasm","volume":"93","author":"Wang","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0115","article-title":"Chromogranin A as surveillance biomarker in patients with carcinoids: CASPAR","author":"Meng","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164065","article-title":"Urinary 5-hydroxyindolacetic acid measurements in patients with neuroendocrine tumor-related carcinoid syndrome: state of the art","volume":"15","author":"Rossi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.rgmxen.2026.09.008_bib0125","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X26000769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X26000769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:43:35Z","timestamp":1792010615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255534X26000769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":25,"alternative-id":["S2255534X26000769"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmxen.2026.09.008","relation":{},"ISSN":["2255-534X"],"issn-type":[{"value":"2255-534X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastroenteropancreatic neuroendocrine neoplasms: A 20-year experience at a tertiary care medical center in Mexico City","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmxen.2026.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2026.02.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}